NL7401117A - - Google Patents

Info

Publication number
NL7401117A
NL7401117A NL7401117A NL7401117A NL7401117A NL 7401117 A NL7401117 A NL 7401117A NL 7401117 A NL7401117 A NL 7401117A NL 7401117 A NL7401117 A NL 7401117A NL 7401117 A NL7401117 A NL 7401117A
Authority
NL
Netherlands
Application number
NL7401117A
Other versions
NL174045C (nl
NL174045B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7401117A publication Critical patent/NL7401117A/xx
Publication of NL174045B publication Critical patent/NL174045B/xx
Application granted granted Critical
Publication of NL174045C publication Critical patent/NL174045C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NLAANVRAGE7401117,A 1973-02-08 1974-01-28 Werkwijze ter bereiding van farmaceutische preparaten met werking op het centrale zenuwstelsel op basis van 6h-thieno-(3,2-f)-s-triazolo(4,3-a) (1,4)diazepinederivaten, alsmede werkwijze ter bereiding van deze derivaten. NL174045C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH179973A CH584223A5 (fi) 1973-02-08 1973-02-08

Publications (3)

Publication Number Publication Date
NL7401117A true NL7401117A (fi) 1974-08-12
NL174045B NL174045B (nl) 1983-11-16
NL174045C NL174045C (nl) 1984-04-16

Family

ID=4218866

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7401117,A NL174045C (nl) 1973-02-08 1974-01-28 Werkwijze ter bereiding van farmaceutische preparaten met werking op het centrale zenuwstelsel op basis van 6h-thieno-(3,2-f)-s-triazolo(4,3-a) (1,4)diazepinederivaten, alsmede werkwijze ter bereiding van deze derivaten.

Country Status (24)

Country Link
JP (1) JPS5833234B2 (fi)
AR (2) AR203188A1 (fi)
AT (1) AT343118B (fi)
BE (1) BE810705A (fi)
CA (1) CA1049009A (fi)
CH (1) CH584223A5 (fi)
DD (1) DD112454A5 (fi)
DE (1) DE2405682C3 (fi)
DK (1) DK137679B (fi)
FI (1) FI58129C (fi)
FR (1) FR2217007B1 (fi)
GB (2) GB1456162A (fi)
HU (2) HU173741B (fi)
IE (1) IE38883B1 (fi)
IL (1) IL44095A (fi)
LU (1) LU69338A1 (fi)
NL (1) NL174045C (fi)
NO (1) NO142260C (fi)
PH (1) PH12303A (fi)
PL (3) PL96107B1 (fi)
SE (1) SE416399B (fi)
SU (3) SU715028A3 (fi)
YU (1) YU39716B (fi)
ZA (1) ZA74472B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT338799B (de) * 1974-03-02 1977-09-12 Boehringer Sohn Ingelheim Verfahren zur herstellung neuer substituierter 6-aryl-4h-s-triazolo-(3,4c)-thieno-(2,3e)-1,4-diazepine und ihrer salze
DE2531678C3 (de) * 1975-07-16 1979-06-28 C.H. Boehringer Sohn, 6507 Ingelheim Thieno [2,3e] triazole [3,4c] 5,6-dihydro-l,4diazepine und Verfahren zu ihrer Herstellung
DE2533924C3 (de) * 1975-07-30 1979-05-03 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von 6- Aryl-4H-striazolo [3,4-c] thieno [2,3-e] 1,4-diazepinen
DE2708121A1 (de) * 1977-02-25 1978-09-07 Boehringer Sohn Ingelheim Triazolo-thieno-diazepin-l-one, verfahren zu ihrer herstellung und arzneimittel
FI63033C (fi) * 1977-07-21 1983-04-11 Boehringer Sohn Ingelheim Foerfarande foer framstaellning av anxiolytiska tranquilliserande sedativa och/eller neuroleptiska substituerade 1-piperazinyl-4h-s-triazolo(3,4-c)tieno(2,3-e)-1,4-diazepiner
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
EP0230942B1 (de) * 1986-01-21 1992-04-29 Boehringer Ingelheim Kg Thieno-1,4-diazepine
JP2582225B2 (ja) * 1994-04-15 1997-02-19 ナショナル住宅産業株式会社 建 具
WO1995032963A1 (fr) * 1994-06-01 1995-12-07 Yoshitomi Pharmaceutical Industries, Ltd. Compose de thienylazole et compose de thienotriazolodiazepine
WO1997009048A1 (en) * 1995-09-09 1997-03-13 F. Hoffmann-La Roche Ag Use of a thienotriazolodiazepine to increase apolipoprotein a-i levels

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904641A (en) * 1971-06-18 1975-09-09 Yoshitomi Pharmaceutical Triazolothienodiazepine compounds

Also Published As

Publication number Publication date
CA1049009A (en) 1979-02-20
YU39716B (en) 1985-04-30
FI58129B (fi) 1980-08-29
HU173741B (hu) 1979-08-28
BE810705A (fr) 1974-08-07
NL174045C (nl) 1984-04-16
GB1456162A (en) 1976-11-17
SU715028A3 (ru) 1980-02-05
PL96107B1 (pl) 1977-12-31
PL97275B1 (pl) 1978-02-28
IL44095A (en) 1979-03-12
NL174045B (nl) 1983-11-16
ATA96474A (de) 1977-09-15
DE2405682A1 (de) 1974-08-15
DD112454A5 (fi) 1975-04-12
SU1060115A3 (ru) 1983-12-07
DK137679C (fi) 1978-09-25
YU22874A (en) 1982-06-30
IL44095A0 (en) 1974-05-16
PH12303A (en) 1979-01-16
NO142260C (no) 1980-07-23
LU69338A1 (fi) 1975-12-09
AR203188A1 (es) 1975-08-22
HU170423B (fi) 1977-06-28
PL97304B1 (pl) 1978-02-28
CH584223A5 (fi) 1977-01-31
NO740405L (no) 1974-08-09
FR2217007B1 (fi) 1978-02-03
DK137679B (da) 1978-04-17
DE2405682B2 (de) 1980-07-17
AU6485574A (en) 1975-07-24
DE2405682C3 (de) 1981-03-12
AR217034A1 (es) 1980-02-29
GB1456161A (en) 1976-11-17
IE38883B1 (en) 1978-06-21
FI58129C (fi) 1980-12-10
IE38883L (en) 1974-08-08
ZA74472B (en) 1974-11-27
NO142260B (no) 1980-04-14
JPS5833234B2 (ja) 1983-07-18
SU747429A4 (ru) 1980-07-23
FR2217007A1 (fi) 1974-09-06
SE416399B (sv) 1980-12-22
JPS49102698A (fi) 1974-09-27
AT343118B (de) 1978-05-10

Similar Documents

Publication Publication Date Title
AR201758A1 (fi)
AU476761B2 (fi)
AU465372B2 (fi)
AR201235Q (fi)
AR201231Q (fi)
AU474593B2 (fi)
AU474511B2 (fi)
AU474838B2 (fi)
AU465453B2 (fi)
AU471343B2 (fi)
AU465434B2 (fi)
AU450229B2 (fi)
AU476714B2 (fi)
AR201229Q (fi)
AU466283B2 (fi)
AU476696B2 (fi)
AU472848B2 (fi)
AR199451A1 (fi)
AU477823B2 (fi)
AU461342B2 (fi)
AU471461B2 (fi)
AR200256A1 (fi)
AU476873B1 (fi)
AR210729A1 (fi)
AU477824B2 (fi)

Legal Events

Date Code Title Description
SNR Assignments of patents or rights arising from examined patent applications

Owner name: F. HOFFMANN-LA ROCHE AG

V4 Discontinued because of reaching the maximum lifetime of a patent